Xtalks Plans Webinar on AI Governance in Clinical Development
Xtalks will host a webinar on AI governance in clinical development on October 13, 2026, at 11 a.m. Eastern Daylight Time, the organization announced in a press release. The free session will cover the governance, data and operational foundations needed to use AI in clinical trials.
Panelists will discuss transparency, model validation, ongoing monitoring, data integrity and human oversight. The program will also address regulatory expectations, staff training and collaboration across clinical development teams.
Speakers include Vivienne van de Walle, founder and medical director of PT&R, and Clare Campbell Cooper, executive director of delivery enablement at Fortrea. Fortrea senior director John Kennett will moderate the webinar.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 30 Suvoda Updates Clinical Trial Platform With AI and Unified Access Sep 30 Medical Image Analysis Software Market Forecast to Reach $6.3 Billion by 2031 Sep 30 Netwrix Finds Identity Governance Gaps at 79% of Healthcare Organizations Sep 30 Insilico Medicine Selects AI Designed Obesity Drug Candidate ISM1354 Sep 29 Truven launches MarketScan Snapshot for healthcare data checksLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
ADLM Calls for CLIA Rules to Cover AI in Laboratory Medicine
Scrum Alliance and Johns Hopkins Launch Healthcare AI Courses
AbbVie Partners With Valkai on AI Tools for Clinical Development
Suvoda Updates Clinical Trial Platform With AI and Unified Access
Daily AI Brief: the AI news that matters, in your inbox.